AffaMed Therapeutics
Dominic Chu has held various positions in different companies. Dominic started their career at KPMG as an Assistant Manager from 2012 to 2015. Dominic later joined Citi as an Associate from 2017 to 2019. After that, they worked at Nomura as a Vice President from 2019 to 2021. Currently, they are serving as the Director of Corporate Finance at AffaMed Therapeutics since 2021.
Dominic Chu completed their Bachelor of Science degree in Accounting and Finance at Indiana University Bloomington from 2006 to 2010. Later, they pursued a Master of Business Administration (MBA) at Cornell Johnson Graduate School of Management from 2015 to 2017.
This person is not in any teams
This person is not in any offices
AffaMed Therapeutics
AffaMed Therapeutics is a clinical stage therapeutic company focused on developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmic, neurological and psychiatric disorders for patients in Greater China and around the world. The leadership team of AffaMed Therapeutics has gained deep industry expertise and an extensive track record in high-quality discovery, clinical development, regulatory affairs, manufacturing, commercial operations, and business development at leading multi-national pharmaceutical companies in China and globally.